Ornicure 150 mg/g Proszek do podania w wodzie do picia Puola - puola - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

ornicure 150 mg/g proszek do podania w wodzie do picia

oropharma n.v. - doxycyclini hyclas - proszek do podania w wodzie do picia - 150 mg/g - gołąb pocztowy; ptaki ozdobne

Tibsovo Euroopan unioni - puola - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Środki przeciwnowotworowe - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.